Interesting. I still find it interesting that you think the first deal will be for pre-clinical Brilacidin indications. Definitely a different take from the herd.

Agree about Prurisol. Good or bad I think we need it to sign a deal. Here's to hoping for a jumbo buyout so that we may all retire comfortably (and soon!)